Journal
INFLAMMATORY BOWEL DISEASES
Volume 21, Issue 6, Pages 1419-1427Publisher
OXFORD UNIV PRESS INC
DOI: 10.1097/MIB.0000000000000344
Keywords
inflammatory bowel disease; viral metagenomics; microbiome
Categories
Funding
- Alberta Innovates Health Solutions
- Broad Foundation
- Canadian Crohn's and Colitis Foundation
- Canadian Institutes for Health Research
- Alberta Innovates Technology Futures
- Janssen
- AbbVie
- Alba
- Bristol-Myers Squibb
- Centocor
- GSK
- Genentech
- Merck
- Millennium
- Novartis
- Pfizer
- Procter Gamble
- Roche
- VSL [3]
- Celltrion
- Beneo-Orafti
- Abbott
- Gilead
Ask authors/readers for more resources
Inflammatory bowel diseases (IBD), Crohn's disease and ulcerative colitis, are poorly understood disorders affecting the intestinal tract. The current model for disease suggests that genetically susceptible patients develop intolerance to gut microflora, and chronic inflammation develops as a result of environmental insults. Although interest has mainly focused on studying genetic variants and gut bacterial flora, little is known about the potential of viral infection to contribute to disease. Accordingly, we conducted a metagenomic analysis to document the baseline virome in colonic biopsy samples from patients with IBD in order to assess the contribution of viral infection to IBD. Libraries were generated from colon RNA to create approximately 2 GB sequence data per library. Using a bioinformatic pipeline designed to detect viral sequences, more than 1000 viral reads were derived directly from tissue without any coculture or isolation procedure. Herein, we describe the complexity and abundance of viruses, bacteria/bacteriophage, and human endogenous retroviral sequences from 10 patients with IBD and 5 healthy subjects undergoing surveillance colonoscopy. Differences in gut microflora and the abundance of mammalian viruses and human endogenous retroviruses were readily detected in the metagenomic analyses. Specifically, patients with herpesviridae sequences in their colon demonstrated increased expression of human endogenous viral sequences and differences in the diversity of their microbiome. This study provides a promising metagenomic approach to describe the colonic microbiome that can be used to better understand virus-host and phage-bacteria interactions in IBD.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available